SCHEMBL15870859

SCHEMBL15870859

CC(C)(O)c1ccc2ccccc2c1-c1ccc(N(c2ccc(-c3ccccc3)cc2)c2ccc(-c3c(C(C)(C)O)ccc4ccccc34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ WDR5 P61964 1/20 0.34
▸ GPR84 Q9NQS5 3/20 0.34
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15865044 0.96 HSD17B10 (0.36) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL2132427 0.91 CYP2C9 (0.42) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL17256119 0.89 GPR84 (0.40) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL14063310 0.88 HSD17B10 (0.45) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL17264195 0.84 KCNJ11 (0.34) HPGDCYP2C9CYP1A2CYP2D6MAPT
SCHEMBL20407302 0.81 GPR84 (0.37) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL15870870 0.80 MEN1 (0.43) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL12671792 0.77 MAPT (0.34) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL13152865 0.77 ALOX5 (0.42) HPGDHSD17B10CYP2C19CYP2C9CYP1A2
SCHEMBL24803603 0.76 GPR84 (0.40) HPGDHSD17B10CYP2C19CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2941472-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-07-25 — — EP disclosed
US-20150329772-A1 Materials for Electronic Devices MERCK PATENT GMBH (DE) 2015-11-19 — — US disclosed
US-20150329772-A1 Materials for Electronic Devices MERCK PATENT GMBH (DE) 2015-11-19 — — US disclosed
WO-2014106522-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2014-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329772-A1 Materials for Electronic Devices EFNA1, SDHB, ETFA HPGD 942/4885HSD17B10 3025/4885CYP2C19 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback